Literature DB >> 17186705

Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways.

U Klingmüller1, A Bauer, S Bohl, P J Nickel, K Breitkopf, S Dooley, S Zellmer, C Kern, I Merfort, T Sparna, J Donauer, G Walz, M Geyer, C Kreutz, M Hermes, F Götschel, A Hecht, D Walter, L Egger, K Neubert, C Borner, M Brulport, W Schormann, C Sauer, F Baumann, R Preiss, S MacNelly, P Godoy, E Wiercinska, L Ciuclan, J Edelmann, K Zeilinger, M Heinrich, U M Zanger, R Gebhardt, T Maiwald, R Heinrich, J Timmer, F von Weizsäcker, J G Hengstler.   

Abstract

Complex cellular networks regulate regeneration, detoxification and differentiation of hepatocytes. By combining experimental data with mathematical modelling, systems biology holds great promises to elucidate the key regulatory mechanisms involved and predict targets for efficient intervention. For the generation of high-quality quantitative data suitable for mathematical modelling a standardised in vitro system is essential. Therefore the authors developed standard operating procedures for the preparation and cultivation of primary mouse hepatocytes. To reliably monitor the dynamic induction of signalling pathways, the authors established starvation conditions and evaluated the extent of starvation-associated stress by quantifying several metabolic functions of cultured primary hepatocytes, namely activities of glutathione-S-transferase, glutamine synthetase, CYP3A as well as secretion of lactate and urea into the culture medium. Establishment of constant metabolic activities after an initial decrease compared with freshly isolated hepatocytes showed that the cultured hepatocytes achieve a new equilibrium state that was not affected by our starving conditions. To verify the highly reproducible dynamic activation of signalling pathways in the in vitro system, the authors examined the JAK-STAT, SMAD, PI3 kinase, MAP kinase, NF-kappaB and Wnt/beta-catenin signalling pathways. For the induction of gp130, JAK1 and STAT3 phosphorylation IL6 was used, whereas TGFbeta was applied to activate the phosphorylation of SMAD1, SMAD2 and SMAD3. Both Akt/PKB and ERK1/2 phosphorylation were stimulated by the addition of hepatocyte growth factor. The time-dependent induction of a pool of signalling competent beta-catenin was monitored in response to the inhibition of GSK3beta. To analyse whether phosphorylation is actually leading to transcriptional responses, luciferase reporter gene constructs driven by multiple copies of TGFbeta-responsive motives were applied, demonstrating a dose-dependent increase in luciferase activity. Moreover, the induction of apoptosis by the TNF-like cytokine Fas ligand was studied in the in vitro system. Thus, the mouse hepatocyte in vitro system provides an important basis for the generation of high-quality quantitative data under standardised cell culture conditions that is essential to elucidate critical hepatocellular functions by the systems biology approach.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186705     DOI: 10.1049/ip-syb:20050067

Source DB:  PubMed          Journal:  Syst Biol (Stevenage)        ISSN: 1741-2471


  57 in total

1.  Snapshots of protein dynamics and post-translational modifications in one experiment--beta-catenin and its functions.

Authors:  Katrin Luckert; Frank Götschel; Peter K Sorger; Andreas Hecht; Thomas O Joos; Oliver Pötz
Journal:  Mol Cell Proteomics       Date:  2011-03-04       Impact factor: 5.911

2.  Fluorescence based cell counting in collagen monolayer cultures of primary hepatocytes.

Authors:  C Priesnitz; S Sperber; R Garg; M Orsini; F Noor
Journal:  Cytotechnology       Date:  2014-11-26       Impact factor: 2.058

3.  Spatial aspects in the SMAD signaling pathway.

Authors:  J Claus; E Friedmann; U Klingmüller; R Rannacher; T Szekeres
Journal:  J Math Biol       Date:  2012-09-18       Impact factor: 2.259

4.  Selective enrichment of newly synthesized proteins for quantitative secretome analysis.

Authors:  Katrin Eichelbaum; Markus Winter; Mauricio Berriel Diaz; Stephan Herzig; Jeroen Krijgsveld
Journal:  Nat Biotechnol       Date:  2012-09-23       Impact factor: 54.908

5.  Hepatic transforming growth factor-β 1 stimulated clone-22 D1 controls systemic cholesterol metabolism.

Authors:  Julia Jäger; Vera Greiner; Daniela Strzoda; Oksana Seibert; Katharina Niopek; Tjeerd P Sijmonsma; Michaela Schäfer; Allan Jones; Roldan De Guia; Marc Martignoni; Geesje M Dallinga-Thie; Mauricio B Diaz; Thomas G Hofmann; Stephan Herzig
Journal:  Mol Metab       Date:  2014-01-08       Impact factor: 7.422

6.  Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes.

Authors:  Titus Sparna; Julia Rétey; Kathrin Schmich; Ute Albrecht; Katrin Naumann; Norbert Gretz; Hans-Peter Fischer; Johannes G Bode; Irmgard Merfort
Journal:  BMC Genomics       Date:  2010-04-07       Impact factor: 3.969

7.  Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions.

Authors:  Cuiping Pan; Chanchal Kumar; Sebastian Bohl; Ursula Klingmueller; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2008-10-23       Impact factor: 5.911

8.  ON/OFF and beyond--a boolean model of apoptosis.

Authors:  Rebekka Schlatter; Kathrin Schmich; Ima Avalos Vizcarra; Peter Scheurich; Thomas Sauter; Christoph Borner; Michael Ederer; Irmgard Merfort; Oliver Sawodny
Journal:  PLoS Comput Biol       Date:  2009-12-11       Impact factor: 4.475

9.  Harmonics of circadian gene transcription in mammals.

Authors:  Michael E Hughes; Luciano DiTacchio; Kevin R Hayes; Christopher Vollmers; S Pulivarthy; Julie E Baggs; Satchidananda Panda; John B Hogenesch
Journal:  PLoS Genet       Date:  2009-04-03       Impact factor: 5.917

10.  Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice.

Authors:  Prachiti Narvekar; Mauricio Berriel Diaz; Anja Krones-Herzig; Ulrike Hardeland; Daniela Strzoda; Sigrid Stöhr; Marcus Frohme; Stephan Herzig
Journal:  Diabetes       Date:  2009-02-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.